PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 16, 2011New England Journal of Medicine2,353 citations

Multiple Myeloma

View Full Paper
APAntonio PalumboKAKenneth C. Anderson

Key Points

  • The aim is to review the biologic features and management strategies for multiple myeloma.
  • Literature review of management techniques for multiple myeloma
  • Analysis of biologic characteristics of myeloma
  • Evaluation of treatment impact on survival
  • Autologous stem-cell transplantation significantly improves treatment outcomes.
  • Thalidomide, lenalidomide, and bortezomib contribute to extended overall survival.
  • Management strategies have evolved to enhance patient care and prognosis.

Abstract

Autologous stem-cell transplantation and agents such as thalidomide, lenalidomide, and bortezomib have changed the management of myeloma and extended overall survival. This review discusses both the biologic features and the management of multiple myeloma.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Palumbo et al. (2011) studied this question.

synapsesocial.com/papers/69df7b2c1113c054a47a1639https://doi.org/10.1056/nejmra1011442
Ask AI
Helpful
Bookmark
Share
View Full Paper